Cargando…
Follow-up in melanoma patients
Due to lack of evidence from prospective clinical trials, the diagnostic procedures, their frequency, as well as the length of the follow-up period in cutaneous melanoma patients should be based on the individual risk of disease recurrence, which is strongly dependent on the stage of disease at the...
Autores principales: | Rutkowski, Piotr, Ługowska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101246/ https://www.ncbi.nlm.nih.gov/pubmed/25089158 http://dx.doi.org/10.1007/s12254-014-0151-y |
Ejemplares similares
-
Follow-up in soft tissue sarcomas
por: Rutkowski, Piotr, et al.
Publicado: (2014) -
Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018) -
Trametinib: a MEK inhibitor for management of metastatic melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015) -
Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019) -
Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures – single-center experience
por: Goryń, Tomasz, et al.
Publicado: (2019)